<?xml version="1.0" encoding="UTF-8"?>
<p>Another point suggesting a possible correlation between PD and T2DM has been demonstrated in the interaction of hypoglycemic and antiparkinsonian drugs. The recent studies took into account the effects of some drugs used to treat PD, such as levodopa, which induces both hyperglycemia and hyperinsulinemia [
 <xref rid="B23" ref-type="bibr">23</xref>], whereas others (including the ergot dopamine agonist bromocriptine) may increase insulin sensitivity [
 <xref rid="B24" ref-type="bibr">24</xref>]. In addition, hypoglycemic drugs such as biguanide [
 <xref rid="B25" ref-type="bibr">25</xref>], sulfonylureas [
 <xref rid="B26" ref-type="bibr">26</xref>], thiazolidinediones [
 <xref rid="B27" ref-type="bibr">27</xref>], and incretinomimetics [
 <xref rid="B28" ref-type="bibr">28</xref>] were used in the management of patients with PD.
</p>
